Sequential advanced pharmacy practice experiences at one institution for students from three pharmacy schools

Rebecca A Taylor1, S Scott Wisneski, Megan A Kaun

  • 1Rebecca A. Taylor, Pharm.D., M.B.A., BCPS, is Pharmacy Manager, Cleveland Clinic Marymount Hospital, Garfield Heights, OH; at the time of writing she was Education Manager, Department of Pharmacy, Cleveland Clinic, Cleveland, OH. S. Scott Wisneski, Pharm.D., M.B.A., is Director of Experiential Education, Assistant Professor of Pharmacy Practice, Northeast Ohio Medical University. Megan A. Kaun, Pharm.D., BCPS, is Director of Advanced Pharmacy Practice Experiences, College of Pharmacy, University of Toledo, Toledo, OH. Patricia Parteleno, Pharm.D., is Director of Experiential Education and Associate Professor, Raabe College of Pharmacy, Ohio Northern University, Ada. Jonathan Williams, Pharm.D., M.S., is Assistant Director, Pharmacy Operations, Cleveland Clinic. Morton P. Goldman, Pharm.D., FCCP, BCPS, is Consultant, American Pharmacotherapy, Cleveland; at the time of writing he was System Director, Academic Affairs and International Business Development, Department of Pharmacy, Cleveland Clinic.

Summary

The sequential advanced pharmacy practice experience (APPE) program enhances student learning and site efficiency. This innovative APPE model offers deeper clinical experience and reduces orientation burden for pharmacy students.

Related Concept Videos

Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
1.2K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
527
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
259
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
423
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
363